Mucodrenol (Ambroxol Hydrochloride)

Ambroxol Hydrochloride, the active ingredient in Mucodrenol, is a mucolytic presented as an oral tablet for oral use. It helps to thin respiratory mucus and is indicated for patients with bronchitis, chronic obstructive pulmonary disease and other conditions characterised by thick sputum. GNH USA supplies Mucodrenol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mucodrenol is a mucolytic that acts on respiratory secretions to improve clearance in several airway conditions. - Acute and chronic bronchitis: reduces mucus viscosity and facilitates expectoration. - Cough with thick or viscous sputum: loosens secretions to ease productive cough. - Chronic obstructive pulmonary disease (COPD): supports mucus clearance and airway patency. - Upper respiratory tract infections: aids in clearing mucus associated with viral or bacterial infections.

Mucodrenol is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Taste disturbance: altered or bitter taste in the mouth. - Gastrointestinal discomfort: nausea, mild abdominal pain or diarrhea. - Skin reactions: mild rash or itching.

Serious or Rare Side Effects: - Allergic reactions: urticaria, angioedema, or anaphylaxis. - Severe skin disorders: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Hematologic effects: eosinophilia or leukopenia.

Before using Mucodrenol, consider the following precautions. - Pregnancy: consult a healthcare professional; data are limited. - Breastfeeding: use with caution; monitor the infant for adverse effects. - Renal impairment: dose adjustment may be required in severe cases. - Asthma: observe for possible bronchospasm, especially in sensitive individuals. - Drug interactions: avoid concurrent use with other mucolytics without medical advice. - Store at ambient temperature: keep in the original packaging, protect from moisture and heat.

Mucodrenol may interact with other medicines; monitor as indicated.

Major Interactions (Avoid): - Concurrent use with other mucolytic agents: may increase gastrointestinal irritation. - Strong CYP2D6 inhibitors (e.g., fluoxetine, quinidine): may raise ambroxol plasma levels.

Moderate Interactions (Monitor Closely): - Antitussives containing codeine: may reduce the expectorant effect of ambroxol. - Bronchodilators (e.g., beta‑agonists): monitor for additive respiratory effects. - Antihistamines: may enhance sedation or drowsiness. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): watch for increased gastric irritation.